TNF-induced modulations of phospholipid metabolism in human breast cancer cells

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1392, Issue 2-3, 1998, Pages 217-232

  Bogin, Liora ^a   Papa, Moshe Z ^a   Polak Charcon, Sylvie ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Breast cancer; Nuclear magnetic resonance; Phosphatidylcholine; Phosphocholine; Tumor necrosis factor

Indexed keywords

CHOLINE; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL GROWTH; ENZYME KINETICS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CHOLINE; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; DEUTERIUM; FLOW CYTOMETRY; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031834628     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00035-6     Document Type: Article

References (52)

1. Beutler B., Cerami A. Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57:1988;505-518.
2. Danforth D.N. Jr., Sgagias M.K. Tumor necrosis factor-α modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro. J. Endocrinol. 138:1993;517-528.
3. Beyaert R., Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. FEBS Lett. 340:1994;9-16.
4. Pagliacci M.C., Fumi G., Migliorati G., Gregnani F., Reccardi C., Nicoletti I. Cytostatic and cytotoxic effects of tumor necrosis factor-α on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones. Lymphokine Cytokine Res. 12:1993;439-447.
5. F.C. Kull, Jr., Tumor necrosis factor/cachectin, in: E.R. Podack (Ed.), Cytolytic Lymphocytes and Complement Effectors of the Immune System, Vol. 2, CRC Press, FL, 1988, pp. 75-89.
6. Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A. Jr., Shepard H.M. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science. 230:1985;943-945.
7. Laster S.M., Wood J.G., Gooding L.R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol. 141:1988;2629-2634.
8. Wang C., Mayo M.W., Baldwin A.S.J. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
9. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumor necrosis factor receptors: Structure and function. Trends Cell Biol. 5:1995;392-399.
10. Hannun Y.A., Obeid L.M. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20:1995;73-77.
11. Heller R.A., Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126:1994;5-9.
12. 2 in breast carcinoma cells. Oncogene. 10:1995;2297-2305.
13. Kozawa O., Suzuki A., Kaida T., Tokuda H., Uematsu T. Tumor necrosis factor-alpha autoregulates interleukin-6 via activation of protein kinase C. Function of sphingosine 1-phosphate and phosphatidylcholine-specific phospholipase C. J. Biol. Chem. 272:1997;25099-25104.
14. 2 expression in glomerular mesangial cells. Eur. J. Clin. Pharmacol. 44:1993;7-9.
15. 2 - a mediator between proximal and distal effectors of inflammation. Immunol. Today. 12:1991;143-146.
16. Schütze S., Berkovic D., Tomsing O., Unger C., Kronke M. Tumor necrosis factor induces rapid production of 1′2′-diacylglycerol by a phosphatidylcholine-specific phospholipase C. J. Exp. Med. 174:1991;975-988.
17. K.J. Longmuir, Biosynthesis and distribution of lipids, in: F. Bronner (Ed.), Current Topics in Membranes and Transport, Vol. 29, Academic Press, Orlando, FL, 1987, pp. 129-174.
18. Exton J.H. Cell signaling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases. Eur. J. Biochem. 243:1997;10-20.
19. Kiss Z., Mukherjee J.J. Phosphocholine and sphingosine-1-phosphate synergistically stimulate DNA synthesis by a MAP kinase-dependent mechanism. FEBS Lett. 412:1997;197-200.
20. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
21. H. Degani, S.M. Ronen, E. Furman, Breast cancer: spectroscopy and imaging of cells and tumors, in: R.J. Gillis (Ed.), NMR in Physiology and Biomedicine, Vol. 1, Academic Press, San Francisco, CA, 1994, pp. 329-351.
22. Furman E., Rushkin E., Margalit R., Bendel P., Degani H. Tamoxifen induced changes in MCF-7 human breast cancer; in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J. Steroid Biochem. Mol. Biol. 43:1992;189-195.
23. H. Degani, E. Furman, MRI/MRS, sex steroids and metabolism; studies of breast cancer. in: Ares-Serono Symposia Series - Frontiers in Endocrinology, Rome, Italy, Ares-Serono Symposia Publications, Rome, 1993.
24. Ting Y.T., Sherr D., Degani H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res. 16:1996;1381-1388.
25. W.D. Stein, Kinetics of transport: analyzing and characterizing models using kinetic approach, in: S. Fleischer, B. Fleischer (Eds.), Methods in Enzymology, Vol. 171, Academic Press, New York, 1989, pp. 23-62.
26. Katz-Brüll R., Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 16:1996;1375-1380.
27. M.G. Ormerod, Flow cytometry: a practical approach, in: D. Rickwood, B.D. Hames (Eds.), The Practical Approach Series, Oxford University Press, New York, 1994.
28. Ronen S., Rushkin E., Degani H. Lipid metabolism of large T47D human breast cancer spheroids; 31P and 13C NMR studies of choline and ethanolamine uptake. Biochim. Biophys. Acta. 1138:1992;203-212.
29. Tyagi R.K., Azrad A., Degani H., Solomon Y. Simultaneous extraction of cellular lipids and water soluble metabolites: evaluation by NMR spectroscopy. Magn. Reson. Med. 35:1996;1-7.
30. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine trisphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
31. Pelech S.L., Vance D.E. Regulation of phosphatidylcholine biosynthesis. Biochim. Biophys. Acta. 779:1984;217-251.
32. 31P NMR studies of cultured human tumor cells: influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed. 3:1990;78-89.
33. Pelech S.L., Vance D.E. Signal transduction via phosphatidylcholine cycles. Trends Biochem. Sci. 14:1989;28-30.
34. Jamil H., Vance D.E. Substrate specificity of CTP:phosphocholine cytidylyltransferase. Biochim. Biophys. Acta. 1086:1991;335-339.
35. Müller G., Ayoub M., Storz P., Rennecke J., Fabbro D., Pfizenmaier K. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1995;1961-1969.
36. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:1994;325-328.
37. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269:1994;3125-3128.
38. Kim M.Y., Linardic C., Obeid L., Hannun Y.A. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon. J. Biol. Chem. 266:1991;484-489.
39. Ohta H., Yatomi Y., Sweeney E.A., Hakomori S., Igarashi Y. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-α in human neutrophils. FEBS Lett. 355:1994;267-270.
40. Podo F., Carpinelli G., Vito M.D., Giannini M., Proietti E., Fiers W., Belardelli F. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice. Cancer Res. 47:1987;6481-6489.
41. Proietti E., Belardelli F., Carpinelli G., Vito M.D., Woodrow D., Moss J., Sestili P., Fiers W., Gresser I., Podo F. Tumor necrosis factor α induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in mice. Int. J. Cancer. 42:1988;582-591.
42. Jakesz R., Smith C.A., Aitken S., Huff K., Schuette W., Shackney S., Lippman M. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 44:1984;619-625.
43. Bajaj P., Lawry J., Shenton G., Rees R.C. Interleukin-6 and tumor necrosis factor alpha synergistically block S-phase cell cycle and upregulate intercellular adhesion molecule-1 expression on MCF7 breast carcinoma cells. Cancer Lett. 71:1993;143-149.
44. Seewaldt V.L., Johnson B.S., Parker M.B., Collins S.J., Swisshelm K. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6:1995;1077-1088.
45. van der Burg B., Rutteman G.R., Blankenstein M.A., de Laat S.W., van Zoelen E.J.J. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J. Cell. Physiol. 134:1988;101-108.
46. Darzynkiewicz Z., Williamson B., Carswell E.A., Old L.J. Cell cycle-specific effects of tumor necrosis factor. Cancer Res. 44:1984;83-90.
47. Shih S., Stutman O. Cell cycle-dependent tumor necrosis factor apoptosis. Cancer Res. 56:1996;1591-1598.
48. 1 phase of the cells cycle. Cancer Res. 51:1991;2379-2385.
49. Sgagias M.K., Kasid A., Danforth D.N. Jr. Interleukin-1α and Tumor necrosis factor-α (TNFα) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol. Endocrinol. 5:1991;1740-1747.
50. Freyer J.P., Schor P.L., Jarrett K.A., Neeman M., Sillerud L.O. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Cancer Res. 51:1991;3831-3837.
51. Smith T.A.D., Eccles S., Ormerod M.G., Tombs A.J., Titley J.C., Leach M.O. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br. J. Cancer. 64:1991;821-826.
52. B.V. Harmon, F.R. Kerr, Definition and incidence of apoptosis: An historical perspective, in: Apoptosis: The Molecular Basis of Cell Death, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1991, pp. 5-23.